Filing excerpt
In collaboration with Merck & Co., Inc. (“Merck”)(1), an oral combination of Merck’s islatravir and lenacapavir is being evaluated as a long-acting HIV treatment...
Source: Autobound Signal API · 68 signals tracked for Gilead · updated
Get Gilead's live signals in Claude or ChatGPT, or by API
What changed at Gilead this week? Use Autobound signals for gilead.com.Gilead is heavily reliant on partnerships for its late-stage pipeline, including collaborations on oncology and virology candidates. This creates a need for solutions that manage complex, multi-party clinical trials, data sharing, and joint regulatory submissions.
Filing excerpt
In collaboration with Merck & Co., Inc. (“Merck”)(1), an oral combination of Merck’s islatravir and lenacapavir is being evaluated as a long-acting HIV treatment...
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Vendors
Vendors named
sec-10kjointVentureGet every 10-K signal for Gilead and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Gilead this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/be56b72d-1870-4c29-ad59-e111943c3ed2 returns this record as JSON. POST /v1/companies/enrich returns every signal for gilead.com.
{
"signal_id": "be56b72d-1870-4c29-ad59-e111943c3ed2",
"signal_type": "sec-10k",
"signal_subtype": "jointVenture",
"detected_at": "2026-03-03T05:50:03.57+00:00",
"company": {
"name": "Gilead",
"domain": "gilead.com"
},
"data": {
"detail": "Gilead is heavily reliant on partnerships for its late-stage pipeline, including collaborations on oncology and virology candidates. This creates a need for solutions that manage complex, multi-party clinical trials, data sharing, and joint regulatory submissions.",
"metrics": {
"timeframe": "multi_year"
},
"summary": "Gilead advances pipeline through strategic collaborations with Merck, Arcellx, and Arcus.",
"excerpts": "In collaboration with Merck & Co., Inc. (“Merck”)(1), an oral combination of Merck’s islatravir and lenacapavir is being evaluated as a long-acting HIV treatment...",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "New entity needs",
"signal_category": "strategic",
"vendors_mentioned": [
"Merck & Co., Inc.",
"Arcellx, Inc.",
"Arcus Biosciences, Inc."
],
"technologies_mentioned": [
"CAR T-cell therapy",
"anti-TIGIT antibody",
"anti-PD-1 monoclonal antibody"
]
}
}
curl https://signals.autobound.ai/v1/signals/be56b72d-1870-4c29-ad59-e111943c3ed2 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gilead.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.